Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cauza, E.
Right arrow Articles by Kostner, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cauza, E.
Right arrow Articles by Kostner, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 1568-1572
© 2003 European Renal Association-European Dialysis and Transplant Association

Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function

Edmund Cauza1, Josef Kletzmaier2, Gert Bodlaj3, Attila Dunky1, Wolfgang Herrmann4 and Karam Kostner3

1 Department of Internal Medicine V, Department of Diabetes, Metabolism and Rheumatology, Wilhelminenspital, 2 Third Department of Medicine, Division of Nephrology and 3 Second Department of Medicine, Division of Cardiology, University of Vienna, Vienna, Austria and 4 Department of Clinical Chemistry, University of the Saarland, Homburg, Germany

Correspondence and offprint requests to: Dr Karam Kostner, AKH Wien, Department of Cardiology, Waehringerguertel 18–20, A-1090 Vienna, Austria. Email: karamkostner{at}hotmail.com

Background. Plasma lipoprotein (a) [Lp(a)] has been shown to be a risk factor for atherosclerosis in numerous studies. However, the catabolism of this lipoprotein is not very clear. We and others have shown that Lp(a) is excreted into urine in the form of fragments. Lp(a) has also been shown to exist in a low-density non-lipoprotein (LDL)-bound form. Since Lp(a) is increased in all forms of kidney disease with reduced excretory kidney function and decreased excretion of apo(a) fragments could be partially responsible for this increase, we investigated the relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function.

Methods. Plasma Lp(a), non-LDL-bound apo(a) and urinary apo(a) fragments were measured in 55 kidney disease patients (28 males and 27 females) and matched controls.

Results. Plasma Lp(a) and non-LDL-bound apo(a) were increased in patients, whereas urinary apo(a) was decreased, especially in patients with a creatinine clearance < 70 ml/min. There was a significant correlation between plasma Lp(a) and non-LDL-bound apo(a) in patients and controls.

Conclusion. We conclude that decreased urinary apo(a) excretion could be one possible mechanism of increased plasma Lp(a) and non-LDL-bound apo(a) in patients with decreased kidney function.

Keywords: lipoprotein (a); non-LDL-bound apo(a); renal function; urinary apo(a)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
P. N.M. Demacker, E. Bolat, H. I. Toenhake-Dijkstra, and L. J.H. van Tits
Factors Influencing Isoprotein Dependency of Polyclonal Apolipoprotein(a) Assays
Clin. Chem., November 1, 2004; 50(11): 2161 - 2163.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.